Performance and cost-effectiveness of selective screening criteria for Chlamydia trachomatis infection in women: Implications for a national chlamydia control strategy

Sexually Transmitted Diseases

Volumn 24, Issue 3, 1997, Pages 131-141

  Marrazzo, Jeanne M ^a,e   Celum, Connie L ^a   Hillis, Susan D ^b   Fine, David ^c   Delisle, Susan ^c   Hunter Handsfield, H ^a,d  

^a UNIVERSITY OF WASHINGTON   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c James Bowman Associates   (United States)

^d PUBLIC HEALTH SEATTLE AND KING COUNTY   (United States)

^e Mailstop 359928   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BACTERIUM DETECTION; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; ENZYME IMMUNOASSAY; FEMALE; FLUORESCENCE; HUMAN; MAJOR CLINICAL STUDY; PREVALENCE; SCREENING TEST; UNITED STATES;

EID: 0030904418     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007435-199703000-00003     Document Type: Article

References (59)

1. Centers for Disease Control and Prevention. Recommendations for the prevention and management of Chlamydia trachomatis infections, 1993. MMWR Morb Mortal Wkly Rep 1993; 42(No. RR-12):1-9.
2. Washington AE, Johnson RE, Sanders LL. Chlamydia trachomatis infections in the United States: What are they costing us? JAMA 1987; 257:2070-2072.
3. American Social Health Association. Update on fiscal year 1994: Funding for the STD Program of the CDC and NIH. Sex Transm Dis 1994; 21:55-58.
4. Stamm WE, Holmes KK. Chlamydia trachomatis infections of the adult. In: Holmes KK, Mårdh P-A, Sparling PF, et al, eds. Sexually transmitted diseases. 2nd ed. New York: McGraw-Hill; 1990:181-193.
5. Stamm WE. Toward control of sexually transmitted chlamydial infections. Ann Intern Med 1993; 119:432-434.
6. Hillis SD, Joesoef R, Marchbanks PA, Wasserheit JN, Cates W, Westrom L. Delayed care of pelvic inflammatory disease as a risk factor for impaired fertility. Am J Obstet Gynecol 1993; 168:1503-1509.
7. Weinstock HS, Bolan GA, Kohn R, Balladares C, Back A, Oliva G. Chlamydia trachomatis infection in women: A need for universal screening in high prevalence populations? Am J Epidemiol 1992; 135:41-47.
8. Trachtenberg AI, Washington AE, Halldorson S. A cost-based decision analysis for chlamydia screening in California family planning clinics. Obstet Gynecol 1988; 71:101-108.
9. Humphreys JT, Henneberry JF, Rickard RS, Beebe JL. Cost-benefit analysis of selective screening criteria for Chlamydia trachomatis infection in women attending Colorado family planning clinics. Sex Transm Dis 1991; 19:47-53.
10. Handsfield HH, Jasman LL, Roberts PL, Hanson VW, Kothenbeutel RL, Stamm WE. Criteria for selective screening for Chlamydia trachomatis infection in women attending family planning clinics. JAMA 1986; 255:1730-1734.
11. Addiss DG, Vaughn ML, Golubjatnikov R, Pfister J, Kurtycz DF, Davis JP. Chlamydia trachomatis infection in women attending urban Midwestern family planing and community health clinics: Risk factors, selective screening, and evaluation of non-culture techniques. Sex Transm Dis 1990; 17:138-146.
12. Winter L, Goldy AS, Baer C. Prevalence and epidemiologic correlates of Chlamydia trachomatis in rural and urban populations. Sex Transm Dis 1990; 17:30-36.
13. Magder LS, Harrison RH, Ehret JM, Anderson TS, Judson FN. Factors related to genital Chlamydia trachomatis and its diagnosis by culture in a sexually transmitted disease clinic. Am J Epidemiol 1988; 128:298-308.
14. Kent GP, Harrison HR, Berman SM, Keenlyside RA. Screening for Chlamydia trachomatis infection in a sexually transmitted disease clinic: Comparison of diagnostic tests with clinical and historical risk factors. Sex Transm Dis 1988; 15:51-57.
15. Winter L, Goldy AS, Baer C. Prevalence and epidemiologic correlates of Chlamydia trachomatis in rural and urban populations. Sex Transm Dis 1990; 17:30-36.
16. Sellors JW, Pickard L, Gafni A, et al. Effectiveness and efficiency of selective vs. universal screening for chlamydial infection in sexually active young women. Arch Intern Med 1992; 152:1837-1844.
17. Magder LS, Harrison RH, Ehret JM, Anderson TS, Judson FN. Factors related to genital Chlamydia trachomatis and its diagnosis by culture in a sexually transmitted disease clinic. Am J Epidemiol 1988; 128:298-308.
18. Britten TF, DeLisle S, Fine D. STDs and family planning clinics: A regional program for Chlamydia control that works. Am J Gynecol Health 1992; 6(3):24-31.
19. Addiss DG, Vaughn ML, Ludka D, Pfister J, Davis JP. Decreased prevalence of Chlamydia trachomatis infection associated with a selective screening program in family planning clinics in Wisconsin. Sex Transm Dis 1993; 20:28-35.
20. Stamm WE, Harrison HR, Alexander ER, Cles LD, Spence MR, Quinn TC. Diagnosis of Chlamydia trachomatis infection by direct immunofluorescence staining of genital secretions: A multicenter trial. Ann Intern Med 1984;101:683-41.
21. Clark A, Stamm WE, Gaydos C, et al. Multicenter evaluation of the AntigEnz chlamydia enzyme immunoassay for diagnosis of Chlamydia trachomatis genital infection. J Clin Microbiol 1992; 30:2762-2764.
22. Kluytmans JA, Niesters HG, Mouton JW, et al. Performance of a nonisotopic DNA probe for detection of Chlamydia trachomatis in urogenital specimens. J Clin Microbiol 1991; 29:2685-2689.
23. Stamm WE, Tamm MR, Koester M, Cles LD. Detection of Chlamydia trachomatis inclusions in McCoy cell cultures with fluorescein-conjugated monoclonal antibodies. J Clin Microbiol 1983; 17:666-668.
24. Eisenberg JM. A guide to the economic analysis of clinical practices. JAMA 1989; 262:2879-2886.
25. Udvarhelyi IS, Colditz GA, Rai A, Epstein AM. Cost-effectiveness and cost-benefit analyses in the medical literature: Are the methods being used correctly? Ann Intern Med 1992; 116:238-244.
26. Stamm WE, Mårdh P-A. Chlamydia trachomatis. In: Holmes KK, Mårdh P-A, Sparling PF, et al, eds. Sexually transmitted diseases. 2nd ed. New York: McGraw-Hill; 1990:917-925.
27. Dille BJ, Butzen CC, Birkenmeyer LG. Amplification of Chlamydia trachomatis DNA by ligase chain reaction. J Clin Microbiol 1993; 31:729-731.
28. Chernesky MA, Lee H, Schachter J, et al. Diagnosis of Chlamydia trachomatis urethral infection in symptomatic and asymptomatic men by testing first-void urine in a ligase chain reaction assay. J Infect Dis 1994; 170:1308-1311.
29. Lee H, Chernesky MA, Schachter J, et al. Diagnosis of Chlamydia trachomatis genitourinary infection in women by ligase chain reaction assay of urine. Lancet 1995; 345:213-216.
30. Statistical Abstracts of the U.S., 1993. Table No. 756: Consumer Price by Major Groups: 1960 to 1992; Table No. 163: Consumer Price Indexes of Medical Prices: 1970 to 1992. Washington, DC: Department of Commerce, Bureau of the Census, 1993.
31. Rolfs RT, Galaid EI, Zaidi AA. Pelvic inflammatory disease: Trends in hospitalizations and office visits, 1979 through 1988. Am J Obstet Gynecol 1992; 166:983-990.
32. Centers for Disease Control and Prevention. A Practical Guide to Prevention Effectiveness: Decision and Economic Analyses. Atlanta, GA: Epidemiology Program Office; 1994.
33. Washington AE, Arno PS, Brooks MA. The economic cost of pelvic inflammatory disease. JAMA 1986; 255:1735-1738.
34. Stamm WE, Guinan ME, Johnson C, Starcher T, Holmes KK, McCormack WM. Effect of treatment regimens for N. gonorrhoeae on simultaneous infection with C. trachomatis. N Engl J Med 1984; 310:545-549.
35. Paavonen J, Kiviat N, Brunham RC, et al. Prevalence and manifestations of endometritis among women with cervicitis. Am J Obstet Gynecol 1985; 152:280-286.
36. Cumining DC. Honore LH, Scott JZ, Williams KE. Microscopic evidence of silent inflammation in grossly normal fallopian tubes with ectopic pregnancy. Int J Fertil 1988; 33:324-328.
37. Cates W, Joesoef MR, Goldman MB. Atypical pelvic inflammatory disease: Can we identify the clinical predictors? Am J Obstet Gynecol 1993; 169:341-346.
38. Cates W, Wasserheit JN. Genital chlamydial infections: Epidemiology and reproductive sequelae. Am J Obstet Gynecol 1991; 164:1771-1781.
39. Westrom L, Bengtsson LPH, Mårdh P-A. Incidence, trends, and risks of ectopic pregnancy in a population of women. Br Med J 1981; 282:15-18.
40. Westrom L, Joesoef R, Reynolds G, Hagdu A, Thompson SE. Pelvic inflammatory disease and fertility: A cohort study of 1844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results. Sex Transm Dis 1992; 19:185-192.
41. Brunham RC, Maclean IW, Binns B, Peeling RW. Chlamydia trachomatis: Its role in tubal infertility. J Infect Dis 1985; 152:1275-1282.
42. Cates W, Rolfs RT, Aral SO. Sexually transmitted diseases, pelvic inflammatory disease, and infertility: An epidemiologic update. Epidemiol Rev 1990; 12:199-220.
43. Sellors JW, Mahoney JB, Chernesky MA, Rath DJ. Tubal factor infertility: An association with prior chlamydial infection and asymptomatic salpingitis. Fertil Steril 1988; 49:451-457.
44. Svensson L, Mårdh PA, Westrom L. Infertility after acute salpingitis with special reference to Chlamydia trachomatis. Fertil Steril 1983; 40:322-329.
45. Hirsch MB, Mosher WD. Characteristics of infertile women in the United States and their use of infertility services. Fertil Steril 1987; 47:618-625.
46. Westrom L. Incidence, prevalence, and trends of acute pelvic inflammatory disease and its consequences in industrialized countries. Am J Obstet Gynecol 1980; 138:880-892.
47. Schachter J, Grossman M, Sweet RL, Holt J, Jordan C, Bishop E. Prospective study of perinatal transmission of Chlamydia trachomatis. JAMA 1986; 255:3374-3377.
48. Hammerschlag MR, Anderlea M, Semine DZ, McComb D, McCormack WM. Prospective study of maternal and infertile infection with Chlamydia trachomatis. Pediatrics 1979; 64:142-148.
49. Tartaglione TA, Russo ME. Pharmacology of drugs used in venereology. In: Holmes KK, Mårdh P-A, Sparling PF, et al, eds. Sexually transmitted diseases. 2nd ed. New York: McGraw-Hill; 1990:993-1019.
50. Katz BP, Caine VA, Jones RB. Estimation of transmission probabilities for chlamydial infection. In: Bowie WR, Caldwell HD, Jones RB, et al, eds. Chlamydia infections. New York: Cambridge University Press; 1990:567-570.
51. Viscidi RP, Bobo L, Hook EW, Quinn TC. Transmission of Chlamydia trachomatis among sex partners assessed by polymerase chain reaction. J Infect Dis 1993; 168:488-492.
52. Stamm WE, Cole B. Asymptomatic Chlamydia trachomatis urethritis in men. Sex Transm Dis 1986; 13:163-165.
53. Stergachis A, Scholes D, Heidrich FE, Sherer DM. Holmes KK, Stamm WE. Selective screening for Chlamydia trachomatis infection in a primary care population of women. Am J Epidemiol 1993; 138:143-153.
54. Nettleman MD, Jones RB, Roberts SD, et al. Cost-effectiveness of culturing for Chlamydia trachomatis: A study in a clinic for sexually transmitted diseases. Ann Intern Med 1986; 105:189-196.
55. Phillips RS, Aronson MD, Taylor WC, Safran C. Should tests for Chlamydia trachomatis cervical infection be done during routine gynecologic visits? Ann Intern Med 1987; 107:188-194.
56. Gene M, Mårdh P-A. A cost-effectiveness analysis of screening and treatment for Chlamydia trachomatis infection in asymptomatic women. Ann Intern Med 1996; 124:1-7.
57. Wager GP, Martin DH, Koutsky L, et al. Puerperal infectious morbidity: Relationship to route of delivery and to antepartum Chlamydia trachomatis infection. Am J Obstet Gynecol 1980; 138:1028-1033.
58. Martius J, Krohn MA, Hillier SL, Stamm WE, Holmes KK, Eschenbach DE. Relationship of vaginal Lactobacillus species, cervical Chlamydia trachomatis, and bacterial vaginosis to preterm birth. Obstet Gynecol 1988; 71:89-95.
59. Gravett MG, Nelson HP, DeRouen T, Critchlow C, Eschenbach DA, Holmes KK. Independent associations of bacterial vaginosis and Chlamydia trachomatis infection with adverse pregnancy outcome. JAMA 1986; 256:1899-1903.